Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52

Chulman Jo; Soner Gundemir; Susanne Pritchard; Youngnam N. Jin; Irfan Rahman; Gail V. W. Johnson

doi:10.1038/ncomms4496

journal article Mar 25, 2014

Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52

Chulman Jo Soner Gundemir Susanne Pritchard Youngnam N. Jin Irfan Rahman

Gail V. W. Johnson

Nature Communications Vol. 5 No. 1 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/ncomms4496

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

Jakob-Roetne, R. & Jacobsen, H. Alzheimer’s disease: from pathology to therapeutic approaches. Angew. Chem. Int. Ed. Engl. 48, 3030–3059 (2009). 10.1002/anie.200802808

[2]

Ballatore, C., Lee, V. M. & Trojanowski, J. Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 8, 663–672 (2007). 10.1038/nrn2194

[3]

Ittner, L. M. & Gotz, J. Amyloid-beta and tau--a toxic pas de deux in Alzheimer's disease. Nat. Rev. Neurosci. 12, 65–72 (2011). 10.1038/nrn2967

[4]

Gong, C. X., Grundke-Iqbal, I. & Iqbal, K. Targeting tau protein in Alzheimer's disease. Drugs Aging 27, 351–365 (2010). 10.2165/11536110-000000000-00000

[5]

Zhang, J. Y., Liu, S. J., Li, H. L. & Wang, J. Z. Microtubule-associated protein tau is a substrate of ATP/Mg(2+)-dependent proteasome protease system. J. Neural Transm. 112, 547–555 (2005). 10.1007/s00702-004-0196-x

[6]

David, D. C. et al. Proteasomal degradation of tau protein. J. Neurochem. 83, 176–185 (2002). 10.1046/j.1471-4159.2002.01137.x

[7]

Carrettiero, D. C., Hernandez, I., Neveu, P., Papagiannakopoulos, T. & Kosik, K. S. The cochaperone BAG2 sweeps paired helical filament- insoluble tau from the microtubule. J. Neurosci. 29, 2151–2161 (2009). 10.1523/jneurosci.4660-08.2009

[8]

Dickey, C. A. et al. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 117, 648–658 (2007). 10.1172/jci29715

[9]

Delobel, P. et al. Proteasome inhibition and Tau proteolysis: an unexpected regulation. FEBS Lett. 579, 1–5 (2005). 10.1016/j.febslet.2004.11.018

[10]

Feuillette, S. et al. Tau is not normally degraded by the proteasome. J. Neurosci. Res. 80, 400–405 (2005). 10.1002/jnr.20414

[11]

Autophagic‐lysosomal perturbation enhances tau aggregation in transfectants with induced wild‐type tau expression

Tadanori Hamano, Tania F. Gendron, Ena Causevic et al.

European Journal of Neuroscience 2008 10.1111/j.1460-9568.2008.06084.x

[12]

Berger, Z. et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 15, 433–442 (2006). 10.1093/hmg/ddi458

[13]

Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing

Yipeng Wang, Marta Martínez-Vicente, Ulrike Krüger et al.

Human Molecular Genetics 2009 10.1093/hmg/ddp367

[14]

Dolan, P. J. & Johnson, G. V. A caspase cleaved form of tau is preferentially degraded through the autophagy pathway. J. Biol. Chem. 285, 21978–21987 (2010). 10.1074/jbc.m110.110940

[15]

Kruger, U., Wang, Y., Kumar, S. & Mandelkow, E. M. Autophagic degradation of tau in primary neurons and its enhancement by trehalose. Neurobiol. Aging 33, 2291–2305 (2011). 10.1016/j.neurobiolaging.2011.11.009

[16]

Khurana, V. et al. Lysosomal dysfunction promotes cleavage and neurotoxicity of tau in vivo. PLoS Genet. 6, e1001026 (2010). 10.1371/journal.pgen.1001026

[17]

Shimada, K. et al. Long-term oral lithium treatment attenuates motor disturbance in tauopathy model mice: implications of autophagy promotion. Neurobiol. Dis. 46, 101–108 (2012). 10.1016/j.nbd.2011.12.050

[18]

Clague, M. J. & Urbe, S. Ubiquitin: same molecule, different degradation pathways. Cell 143, 682–685 (2010). 10.1016/j.cell.2010.11.012

[19]

Johansen, T. & Lamark, T. Selective autophagy mediated by autophagic adapter proteins. Autophagy 7, 279–296 (2011). 10.4161/auto.7.3.14487

[20]

Salminen, A. et al. Emerging role of p62/sequestosome-1 in the pathogenesis of Alzheimer’s disease. Prog. Neurobiol. 96, 87–95 (2012). 10.1016/j.pneurobio.2011.11.005

[21]

Komatsu, M. et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell. Biol. 12, 213–223 (2010). 10.1038/ncb2021

[22]

Jain, A. et al. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J. Biol. Chem. 285, 22576–22591 (2010). 10.1074/jbc.m110.118976

[23]

Ramesh Babu, J. et al. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J. Neurochem. 106, 107–120 (2008). 10.1111/j.1471-4159.2008.05340.x

[24]

Kirkin, V. et al. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol. Cell 33, 505–516 (2009). 10.1016/j.molcel.2009.01.020

[25]

Wenger, T. et al. Autophagy inhibition promotes defective neosynthesized proteins storage in ALIS, and induces redirection toward proteasome processing and MHCI-restricted presentation. Autophagy 8, 350–363 (2012). 10.4161/auto.18806

[26]

D'Agostino, C., Nogalska, A., Cacciottolo, M., Engel, W. K. & Askanas, V. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol. 122, 627–636 (2011). 10.1007/s00401-011-0874-3

[27]

Mostowy, S. et al. p62 and NDP52 proteins target intracytosolic Shigella and Listeria to different autophagy pathways. J. Biol. Chem. 286, 26987–26995 (2011). 10.1074/jbc.m111.223610

[28]

Thurston, T. L., Ryzhakov, G., Bloor, S., von Muhlinen, N. & Randow, F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat. Immunol. 10, 1215–1221 (2009). 10.1038/ni.1800

[29]

Inomata, M., Niida, S., Shibata, K. & Into, T. Regulation of Toll-like receptor signaling by NDP52-mediated selective autophagy is normally inactivated by A20. Cell Mol. Life Sci. 69, 963–979 (2012). 10.1007/s00018-011-0819-y

[30]

Tumbarello, D. A. et al. Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome. Nat. Cell Biol. 14, 1024–1035 (2012). 10.1038/ncb2589

[31]

Kanninen, K., White, A. R., Koistinaho, J. & Malm, T. Targeting glycogen synthase kinase-3beta for therapeutic benefit against oxidative stress in Alzheimer's Disease: involvement of the Nrf2-ARE pathway. Int. J. Alzheimers Dis. 2011, 985085 (2011). 10.4061/2011/985085

[32]

Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway

Thomas W. Kensler, Nobunao Wakabayashi, Shyam Biswal

Annual Review of Pharmacology and Toxicology 2007 10.1146/annurev.pharmtox.46.120604.141046

[33]

Kanninen, K. et al. Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 106, 16505–16510 (2009). 10.1073/pnas.0908397106

[34]

Hur, W. & Gray, N. S. Small molecule modulators of antioxidant response pathway. Curr. Opin. Chem. Biol. 15, 162–173 (2011). 10.1016/j.cbpa.2010.12.009

[35]

Liu, F., Grundke-Iqbal, I., Iqbal, K. & Gong, C. X. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942–1950 (2005). 10.1111/j.1460-9568.2005.04391.x

[36]

Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S. & Mumby, M. C. Regulation of the phosphorylation state and microtubule-binding activity of Tau by protein phosphatase 2A. Neuron 17, 1201–1207 (1996). 10.1016/s0896-6273(00)80250-0

[37]

Klionsky, D. J., Elazar, Z., Seglen, P. O. & Rubinsztein, D. C. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 4, 849–950 (2008). 10.4161/auto.6845

[38]

Thurston, T. L., Wandel, M. P., von Muhlinen, N., Foeglein, A. & Randow, F. Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion. Nature 482, 414–418 (2012). 10.1038/nature10744

[39]

Sarkar, S., Davies, J. E., Huang, Z., Tunnacliffe, A. & Rubinsztein, D. C. Trehalose, a novel mTOR-independent autophagy enhancer, accelerates the clearance of mutant huntingtin and alpha-synuclein. J. Biol. Chem. 282, 5641–5652 (2007). 10.1074/jbc.m609532200

[40]

Watanabe, Y. & Tanaka, M. p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. J. Cell. Sci. 124, 2692–2701 (2011). 10.1242/jcs.081232

[41]

Steinhilb, M. L. et al. S/P and T/P phosphorylation is critical for tau neurotoxicity in Drosophila. J. Neurosci. Res. 85, 1271–1278 (2007). 10.1002/jnr.21232

[42]

Berger, Z. et al. Accumulation of pathological tau species and memory loss in a conditional model of tauopathy. J. Neurosci. 27, 3650–3662 (2007). 10.1523/jneurosci.0587-07.2007

[43]

Brunden, K. R., Trojanowski, J. Q. & Lee, V. M. Evidence that non-fibrillar tau causes pathology linked to neurodegeneration and behavioral impairments. J. Alzheimers Dis. 14, 393–399 (2008). 10.3233/jad-2008-14406

[44]

Petrucelli, L. et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703–714 (2004). 10.1093/hmg/ddh083

[45]

Shimura, H., Schwartz, D., Gygi, S. P. & Kosik, K. S. CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279, 4869–4876 (2004). 10.1074/jbc.m305838200

[46]

Dickey, C. A. et al. Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci. 26, 6985–6996 (2006). 10.1523/jneurosci.0746-06.2006

[47]

Dickey, C. A. et al. HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J. 20, 753–755 (2006). 10.1096/fj.05-5343fje

[48]

Watson, R. O., Manzanillo, P. S. & Cox, J. S. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 150, 803–815 (2012). 10.1016/j.cell.2012.06.040

[49]

Cho, J. H. & Johnson, G. V. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J. Biol. Chem. 279, 54716–54723 (2004). 10.1074/jbc.m403364200

[50]

Cho, J. H. & Johnson, G. V. Glycogen synthase kinase 3beta phosphorylates tau at both primed and unprimed sites. Differential impact on microtubule binding. J. Biol. Chem. 278, 187–193 (2003). 10.1074/jbc.m206236200

Showing 50 of 53 references

Cited By

285

A variant of the autophagic receptor NDP52 counteracts phospho-TAU accumulation and emerges as a protective factor for Alzheimer’s disease

Anna Mattioni, Claudia Carsetti · 2025

Cell Death & Disease

The KEAP1-NRF2 System and Neurodegenerative Diseases

Akira Uruno, Masayuki Yamamoto · 2023

Antioxidants & Redox Signaling

Autophagy in major human diseases

Daniel J Klionsky, Giulia Petroni · 2021

The EMBO Journal

Curcumin activates Nrf2 through PKCδ-mediated p62 phosphorylation at Ser351

Jee-Yun Park, Hee-Young Sohn · 2021

Scientific Reports

Redox regulation by NRF2 in aging and disease

Cody J. Schmidlin, Matthew B. Dodson · 2019

Free Radical Biology and Medicine

p62/ SQSTM1 and Selective Autophagy in Cardiometabolic Diseases

Se-Jin Jeong, Xiangyu Zhang · 2019

Antioxidants & Redox Signaling

Nrf2 at the heart of oxidative stress and cardiac protection

Qin M. Chen, Anthony J. Maltagliati · 2018

Physiological Genomics

Selective autophagy as a potential therapeutic target for neurodegenerative disorders

Aurora Scrivo, Mathieu Bourdenx · 2018

The Lancet Neurology

Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer’s disease

Isabel Gameiro, Patrycja Michalska · 2017

Scientific Reports

Metrics

285

Citations

53

References

Details

Published: Mar 25, 2014
Vol/Issue: 5(1)
License: View

Authors

Department of Environmental Medicine, University of Rochester Medical Center, Rochester, NY, USA

G

Gail V. W. Johnson

Cite This Article

Chulman Jo, Soner Gundemir, Susanne Pritchard, et al. (2014). Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52. Nature Communications, 5(1). https://doi.org/10.1038/ncomms4496

Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52

You May Also Like